Dr. Annabella Shewarega

Biography

Annabella Shewarega is a resident in Interventional Radiology at Yale New Haven Hospital and a PhD candidate in Biology at the University of Duisburg-Essen, Germany. Her research focuses on developing non-invasive imaging biomarkers and novel locoregional immunotherapy strategies for liver cancer. She began her interest in interventional oncology during her doctoral research at the Yale Interventional Oncology Lab, where she investigated combination ablative treatments and immunoadjuvants to study their effects on the tumor immune microenvironment. Annabella has led and contributed to studies aimed at identifying immune imaging-based biomarkers to guide personalized treatment strategies and predict therapeutic immunologic responses to locoregional interventions. Prior to her residency, she completed postdoctoral training at the Yale Interventional Oncology Lab, where her work emphasized characterizing the liver tumor microenvironment using advanced imaging, quantitative analysis, and immunologic profiling techniques. Her projects leverage a strong foundation in preclinical research methods and translational models of liver cancer, particularly focusing on inflammation-driven mouse tumor systems and the VX2 rabbit model. Her research has been supported by multiple awards and fellowships, including funding from the German Academic Exchange Service (DAAD) and the Society of Interventional Oncology Research Grant. Annabella aims to bridge imaging science and therapeutic innovation to advance personalized, image-guided cancer care.

Research Interests

Experience